Matches in Nanopublications for { ?s ?p "[Our findings therefore show that HI-TOPK-032 is a specific inhibitor of TOPK both in vitro and in vivo that may be further developed as a potential therapeutic against colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP616782.RAY-2DxweSPYlzZepUGsDoz1tua_Z3q7tOIouz2obZAZk130_assertion description "[Our findings therefore show that HI-TOPK-032 is a specific inhibitor of TOPK both in vitro and in vivo that may be further developed as a potential therapeutic against colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616782.RAY-2DxweSPYlzZepUGsDoz1tua_Z3q7tOIouz2obZAZk130_provenance.
- NP330085.RAvszqSz7PrR3EzN66693EBTDPUP96Th7oEH2AC1KwYxc130_assertion description "[Our findings therefore show that HI-TOPK-032 is a specific inhibitor of TOPK both in vitro and in vivo that may be further developed as a potential therapeutic against colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP330085.RAvszqSz7PrR3EzN66693EBTDPUP96Th7oEH2AC1KwYxc130_provenance.
- assertion description "[Our findings therefore show that HI-TOPK-032 is a specific inhibitor of TOPK both in vitro and in vivo that may be further developed as a potential therapeutic against colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Our findings therefore show that HI-TOPK-032 is a specific inhibitor of TOPK both in vitro and in vivo that may be further developed as a potential therapeutic against colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP976489.RAIJbAIYLYZtlFyVOkEsbkZ0aIaJIwlLZUk0Umvcl5DmM130_assertion description "[Our findings therefore show that HI-TOPK-032 is a specific inhibitor of TOPK both in vitro and in vivo that may be further developed as a potential therapeutic against colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP976489.RAIJbAIYLYZtlFyVOkEsbkZ0aIaJIwlLZUk0Umvcl5DmM130_provenance.
- NP921632.RANS417QdSZRf1WI0qFVfmlJvFOnMMAOTw1arX3pAoBeQ130_assertion description "[Our findings therefore show that HI-TOPK-032 is a specific inhibitor of TOPK both in vitro and in vivo that may be further developed as a potential therapeutic against colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921632.RANS417QdSZRf1WI0qFVfmlJvFOnMMAOTw1arX3pAoBeQ130_provenance.
- NP921680.RAkYbMbE8vjPVq0TwKAVx5QIQ-7tS9gqSP7Yk4Mahtdr4130_assertion description "[Our findings therefore show that HI-TOPK-032 is a specific inhibitor of TOPK both in vitro and in vivo that may be further developed as a potential therapeutic against colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921680.RAkYbMbE8vjPVq0TwKAVx5QIQ-7tS9gqSP7Yk4Mahtdr4130_provenance.
- NP976488.RAhrdTlaUoyrk3-FikW1vPOk2oxt19tJ_g_UFUKUD4yXo130_assertion description "[Our findings therefore show that HI-TOPK-032 is a specific inhibitor of TOPK both in vitro and in vivo that may be further developed as a potential therapeutic against colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP976488.RAhrdTlaUoyrk3-FikW1vPOk2oxt19tJ_g_UFUKUD4yXo130_provenance.